Weekly Recap | Eli Lilly -2.93%, closing $3.8 billion dealWeekly Review·Sep 12 at 06:15 AMLLY-0.19%LLYX-0.04%
Weekly Recap | Eli Lilly -2.15%, most brokers rate it buyWeekly Review·Sep 5 at 07:19 AMLLY-0.19%LLYX-0.04%
Weekly Recap | Eli Lilly -6.44%, FDA clears Mounjaro heart-risk labelWeekly Review·Aug 29 at 05:57 AMLLY-0.19%LLYX-0.04%
Weekly Recap | Eli Lilly +6.38%, closing in on record highsWeekly Review·Aug 22 at 05:14 AMLLY-0.19%LLYX-0.04%
